Aptamer Group PLC (AIM: APTA)
Health Care · Biotechnology · GB
£0.00
+1.54% today · -64.9% 1Y
Aptamer Group PLC (AIM: APTA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $14.86M.
Over the last twelve months the share price has lost 64.9%, trading between 0.00 and 0.01.
Tweenvest scores Aptamer Group PLC across four factors: quality 36/100, value 58/100, growth 91/100. Its strongest factor is growth.
APTA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.86M
- Revenue (TTM)
- $1.85M
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.85
- 52-week high
- £0.01
- 52-week low
- £0.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.46B
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Poongjeon Pharmacy CO.,LTD.KOSDAQ: A298060 | $15.29M | ₩2,330.00 | -4.51% |
| Read-Gene S.A.WSE: RDG | $15.28M | zł5.00 | -0.79% |
| FunPep Company LimitedTSE: 4881 | $15.10M | ¥47.00 | -4.08% |
| Xintela AB (publ)OM: XINT | $14.98M | Skr0.16 | -8.88% |
| SenzaGen ABOM: SENZA | $14.67M | Skr4.64 | +2.43% |
| HST Global, Inc.OTCPK: HSTC | $14.14M | $0.10 | -85.71% |
| Abera Bioscience ABNGM: ABERA | $14.09M | Skr6.86 | +2.39% |
| AEON Biopharma, Inc.NYSEAM: AEON | $13.92M | $0.31 | +11.11% |
Figures last refreshed Oct 4, 2026.